Profile
Anders Ohberg currently works at Norrlandsfonden, as Chairman, Cinclus Pharma Holding AB, as Independent Non-Executive Director from 2016, and Regulus Pharma Fas i AB, as Director.
Mr. Ohberg also formerly worked at PTC Therapeutics, Inc., as Medical Director from 2023 to 2025.
Mr. Ohberg received his graduate degree from the University of Uppsala.
Anders Ohberg active positions
| Companies | Position | Start |
|---|---|---|
| CINCLUS PHARMA HOLDING AB | Director/Board Member | 2015-12-31 |
Norrlandsfonden
Norrlandsfonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Chairman | - |
Regulus Pharma Fas i AB | Director/Board Member | - |
Former positions of Anders Ohberg
| Companies | Position | End |
|---|---|---|
| PTC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-01-31 |
Training of Anders Ohberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norrlandsfonden
Norrlandsfonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Operates as a holding company through its subsidiaries develops small molecules for treatment of gastric acid related diseases | Health Technology |
Regulus Pharma Fas i AB |
- Stock Market
- Insiders
- Anders Ohberg
















